Engineers Gate Manager’s Xeris Biopharma Holdings XERS Stock Holding History

Engineers Gate Manager’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-185,911	Closed	-$1.08M	–	2682
2026 Q1	$1.08M	Buy	185,911 +96,507	+108%	+$640K	0.01%	1006
2025 Q4	$702K	Sell	89,404 -20,590	-19%	-$162K	0.01%	1202
2025 Q3	$895K	Buy	109,994 +71,954	+189%	+$478K	0.01%	1205
2025 Q2	$178K	Buy	+38,040	New	+$174K	﹤0.01%	1918
2019 Q4	–	Sell	-20,264	Closed	-$199K	–	1869
2019 Q3	$199K	Buy	+20,264	New	+$228K	0.01%	1204
2019 Q2	–	Sell	-42,333	Closed	-$425K	–	1403
2019 Q1	$425K	Buy	+42,333	New	+$542K	0.03%	648

Other funds holding XERS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Engineers Gate Manager's XERS Position: Q2 2026 in Review

Engineers Gate Manager sold out of Xeris Biopharma Holdings (XERS) in Q2 2026, closing a stake of 185,911 shares — an estimated $1.08M sold.

Engineers Gate Manager first reported a position in XERS in Q1 2019 and held it in 6 quarters. The position peaked at $1.08M in Q1 2026. 241 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

Engineers Gate Manager reported no remaining Xeris Biopharma Holdings position as of Q2 2026 after selling out during the quarter.
Engineers Gate Manager sold 185,911 Xeris Biopharma Holdings shares in Q2 2026, an estimated $1.08M.
Engineers Gate Manager first reported a position in Xeris Biopharma Holdings in Q1 2019 and held it in 6 quarters.
Engineers Gate Manager's Xeris Biopharma Holdings position peaked at $1.08M in Q1 2026.
241 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.